Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Human immunomodulation and initial HIV spread

Full text
Author(s):
Joly, Marcel [1, 2] ; Odloak, Darci [2] ; Rondo, Patricia H. C. [1]
Total Authors: 3
Affiliation:
[1] Univ Sao Paulo, Dept Nutr, Sch Publ Hlth, BR-01246904 Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Proc Control & Simulat Lab, Dept Chem Engn, BR-05508900 Sao Paulo, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Computers & Chemical Engineering; v. 84, p. 255-280, JAN 4 2016.
Web of Science Citations: 3
Abstract

We use published data in order to build up a networked mathematical framework aiming at providing: (a) a predictive understanding on how distinct stressors and immunosenescence may potentially affect the natural inflammatory response mechanisms and (b) new insights to developing early interventions that seek to exploit natural immune processes. Relying on fifty fundamental assumptions on HIV immunopathogenesis, the model simulations suggested that: (a) from a translational perspective, forthcoming physiological transitions in the systemic inflammation process do exist with conditions for bifurcation between the uninfected and the infected state being seriously impacted by immunomodulation and (b) the required therapy efficacy for pre-exposure prophylaxis may be decisively affected by immunomodulation and by the drug class used. Whereas unsuitable to make quantitative predictions due to limited experimental data and the complexity in vivo, this modeling effort paves the way for assessing the impact of personalized medicine for global epidemics within complex systems thinking. (C) 2015 Elsevier Ltd. All rights reserved. (AU)